Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 44, Issue 8, 2001, Pages 1754-1760

  Jain, Abhilash ^a   Nanchahal, Jagdeep ^a   Troeberg, Linda ^b   Green, Patricia ^b   Brennan, Fionula ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYTOKINE; GELATINASE A; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TENDON;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; SYNOVIAL MEMBRANE; TENDONS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WRIST JOINT;

EID: 0034887303     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200108)44:8<1754::AID-ART310>3.0.CO;2-8     Document Type: Article

References (18)

1. Rheumatoid flexor tenosynovitis and rupture
2. Extensor tendon ruptures in rheumatoid arthritis
3. Flexor tendon ruptures in rheumatoid arthritis
4. Flexor tendon ruptures in patients with rheumatoid arthritis
5. Rheumatoid extensor tendon ruptures
6. Ultrastructural causes of rupture of hand tendons in patients with rheumatoid arthritis: A transmission and scanning electron microscopic study
7. Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases
8. Using inhibitors of metalloproteinases to treat arthritis: Easier said than done?
9. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
10. Role of cytokines in experimental arthritis
11. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
12. Matrix metalloproteinase-2 is an interstitial collagenase: Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4- length fragments
13. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumor necrosis factor-alpha (cA2) therapy
14. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
15. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
16. Evaluation of human TNF in plasma by ELISA
17. p55 and p75 tumour necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts
18. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells